tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Intellia Therapeutics price target lowered to $30 from $36 at BofA
PremiumThe FlyIntellia Therapeutics price target lowered to $30 from $36 at BofA
3d ago
Beam Therapeutics initiated with a Buy at Jefferies
Premium
The Fly
Beam Therapeutics initiated with a Buy at Jefferies
21d ago
Beam Therapeutics price target lowered to $46 from $48 at JPMorgan
Premium
The Fly
Beam Therapeutics price target lowered to $46 from $48 at JPMorgan
21d ago
Beam Therapeutics: Strong Buy Rating Backed by Advancements in Genetic Medicine Programs
PremiumRatingsBeam Therapeutics: Strong Buy Rating Backed by Advancements in Genetic Medicine Programs
1M ago
Strategic Positioning and Technological Advancements Drive Buy Rating for Beam Therapeutics
Premium
Ratings
Strategic Positioning and Technological Advancements Drive Buy Rating for Beam Therapeutics
2M ago
Beam competitive position intact after Wave data, says Clear Street
Premium
The Fly
Beam competitive position intact after Wave data, says Clear Street
2M ago
Cathie Wood’s ARK Investment buys 395K shares of Beam Therapeutics today
PremiumThe FlyCathie Wood’s ARK Investment buys 395K shares of Beam Therapeutics today
2M ago
Beam Therapeutics announces U.S. FDA granted RMAT to BEAM-101
Premium
The Fly
Beam Therapeutics announces U.S. FDA granted RMAT to BEAM-101
3M ago
3 Small-Cap Stocks That Could Double Your Money, According to Analysts
Premium
Market News
3 Small-Cap Stocks That Could Double Your Money, According to Analysts
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100